Dysplastic nevus: The eye of the hurricane

Journal of Cutaneous Pathology

Volumn 35, Issue SUPPL. 2, 2008, Pages 16-19

  Arumi Uria, Montserrat ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CLINICAL FEATURE; DYSPLASTIC NEVUS; FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME; FAMILY HISTORY; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; MELANOMA; REVIEW; SKIN PIGMENTATION;

DYSPLASTIC NEVUS SYNDROME; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 54049152438     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01142.x     Document Type: Review

References (29)

1. Clark WH Jr., Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions. "The B-K mole syndrome". Arch Dermatol 1978 114 : 732.
2. Norris W. A case of fungoid disease. Edinb Med Surg J 1820 16 : 562.
3. Cawley EP, Kruse WT, Pinkus HK. Genetic aspects of malignant melanoma. AMA Arch Dermatol 1952 65 : 440.
4. Lynch HT, Frichot BC, Lynch JF. Familial multiple mile-melanoma syndrome. J Med Genet 1978 15 : 352.
5. Elder DE, Goldman LI, Goldman SC, Greene MH, Clark WH Jr. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer 1980 46 : 1787.
6. Ackerman AB, Mihara I. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanoma. Hum Pathol 1985 16 : 87.
7. Ackerman AB. What a naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology 1988 13 : 241.
8. Sagebiel RW. The dysplastic melanocytic nevus. J Am Acad Dermatol 1989 20 : 496.
9. Ackerman AB, Magna-Garcia N. Naming acquired melanocytic nevi. Unnas's Miescher's, Sptiz's, Clark's. Am J Dermatopathol 1990 1 : 193.
10. Mehregan AH. Dysplastic nevi: a histopathological investigation. J Cutan Pathol 1988 15 : 276.
11. Cook MG, Fallowfield ME. Dysplastic naevi - an alternative view. Histopathology 1990 16 : 29.
12. Smoller BR, Egbert BM. Dysplastic nevi can be diagnosed and graded reproducibly: a longitudinal study. J Am Acad Dermatol 1992 27 : 399.
13. Duncan LM, Berwick M, Bruijn JA, Byers R, Mihm MC, Barnhill RL. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol 1993 100 (3 Suppl 318.
14. Freinkel RK, Cage CW, Caro WA, et al. Consensus Conference. Precursors to malignant melanoma. JAMA 1984 251 : 1864.
15. NIH Consensus Development Panel on Early Melanoma. NIH Consensus Conference: diagnosis and treatment of early melanoma. JAMA 1992 268 : 1314.
16. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number or melanocytic nevi as major risk factor for malignant melanoma. J Am Acad Dermatol 1987 17 : 459.
17. Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985 45 : 1855.
18. Grob JJ, Andrac L, Romano MH, et al. Dysplastic nevus in non-familial melanoma. A clinico-pathological study of 101 cases. Br J Dermatol 1988 118 : 745.
19. Crutcher WA, Sagebiel RW. Prevalence of dysplastic naevi in a community practice (Letter). Lancet 1984 1 : 729.
20. Roush GC, Nordlung JJ, Forget B, Gruber SB, Kirkwood JM. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma. Prev Med 1988 17 : 273.
21. Halpern AC, Guerry D IV, Elder DE, et al. Dysplastic nevi as a risk markers of sporadic (nonfamilial) melanoma: a case-control study. Arch Dermatol 1991 127 : 995.
22. Garbe C, Büttner P, Weiss J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society. J Invest Dermatol 1994 102 : 695.
23. Titus-Ernstoff L, Duray PH, Ernstoff MS, Barnhill RL, Horn PL, Kirkwood JM. Dysplastic nevi in association with multiple primary melanoma. Cancer Res 1988 48 : 1016.
24. Black WC. Residual dysplastic and other nevi in superficial spreading melanoma: clinical correlation and association with sun damage. Cancer 1988 62 : 163.
25. Hastrup N, Osterlind A, Drzewiecki RK, Jou-Jensen K. The presence of dysplastic nevus remnants in malignant melanomas: a population based study of 551 malignant melanomas. Am J Dermatopathol 1991 13 : 378.
26. Christopherson WM. Dysplasia, carcinoma in situ, and microinvasive carcinoma of the uterine cervix. Hum Pathol 1977 8 : 489.
27. Ming SC, Bajtai A, Correa P, et al. Gastric dysplasia. Significance and pathologic criteria. Cancer 1984 54 : 1794.
28. Arumi-Uria M, McNutt NS, Finnerty B. Grading of atypia in nevi: correlation with melanoma risk. Mod Pathol 2003 16 : 764.
29. Shea CR, Vollmer RT, Prieto VG. Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol 1999 30 : 500.